1. Membrane Transporter/Ion Channel
    Neuronal Signaling
  2. iGluR

iGluR

iGluR Related Products (59):

Cat. No. Product Name Effect Purity
  • HY-15084
    (+)-MK 801 (Maleate) Antagonist
    (+)-MK 801 (Maleate) is a potent, selective and non-competitive NMDA receptor antagonist with Kd of 37.2 nM in rat brain membranes.
  • HY-17551
    NMDA Agonist
    NMDA is a specific agonist for NMDA receptor mimicking the action of glutamate, the neurotransmitter which normally acts at that receptor.
  • HY-16312
    MDL-29951 Antagonist
    MDL-29951 is a novel glycine antagonist of NMDA receptor activation, with Ki of 0.14 mM for [3H]glycine binding in vitro and in vivo.
  • HY-B0365A
    Memantine hydrochloride Inhibitor
    Memantine, an amantadine derivative with low to moderate-affinity for NMDA receptors, inhibit CYP2B6 and CYP2D6 with Ki of 0.51 nM and 94.9 μM, respectively.
  • HY-10935
    LY450108 Activator
    LY450108 is an alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptor potentiator.
  • HY-10937
    Farampator Modulator
    Farampator (CX-691;Org24448) is an AMPA receptor positive modulator.
  • HY-15067
    DNQX Antagonist
    DNQX is a AMPA receptor antagonists.
  • HY-17550
    Sunifiram Agonist
    Sunifiram (DM-235) is a piperazine derived ampakine-like drug which has nootropic effects in animal studies with significantly higher potency than piracetam.
  • HY-15079
    Talampanel Antagonist
    Talampanel is a potent and selective AMPA-receptor antagonist, is a potential new antiepileptic drug (AED).
  • HY-15703
    QNZ46 Antagonist
    QNZ46 is a NR2C/NR2D-selective NMDA receptor non-competitive antagonist (IC50 values are 3, 6, 229, and >300, >300 μM for NR2D, NR2C, NR2A, NR2B, and GluR1, respectively).
  • HY-17456
    Noopept Agonist
    Noopept (GVS-111) is a medication promoted and prescribed in Russia and neighbouring countries as a nootropic.
  • HY-15085
    MDL 105519 Inhibitor
    MDL 105519 is a potent and selective inhibitor of [3H]glycine binding to the NMDA receptor with Kd of 3.89 nM.
  • HY-13059
    SDZ 220-581 Antagonist
    SDZ 220-581 is a potent, competitive antagonist at the NMDA glutamate receptor subtype(pKi= 7.7).
  • HY-B0184
    Felbamate Inhibitor
    Felbamate (FBM) is a potent nonsedative anticonvulsant whose clinical effect may be related to the inhibition of N-methyl-D-aspartate (NMDA) .
  • HY-10934
    LY451395 Activator
    LY451395(Mibampator) is a potent and highly selective potentiator of the AMPA receptors.
  • HY-10932
    Aniracetam Modulator
    Aniracetam(Ro 13-5057) is a nootropics and neuroprotective drug, which is selectively modulates the AMPA receptor and nAChR.
  • HY-10933
    Ampalex Modulator
    Ampalex (Ampakine CX516; CX516; BDP 12) is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator as a treatment for Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI).
  • HY-17001
    Flupirtine Maleate Antagonist
    Flupirtine Maleate(D 9998) is a selective neuronal potassium channel opener that also has NMDA receptor antagonist properties.
  • HY-17553
    Coluracetam Activator
    Coluracetam(MKC-231) is a new choline uptake enhancer.
  • HY-15069
    ZK200775 Antagonist
    ZK200775(Fanapanel; MPQX) is a highly selective AMPA/kainate antagonist with little activity against NMDA; have Ki values of 3.2 nM, 100 nM, and 8.5 μM against quisqualate, kainate, and NMDA, respectively.